NORTHRIDGE, California, July 5, 2011 /Newswire — Imperia Entertainment, Inc. (Pink Sheets: IMPN) http://imperiaentertainment.com announced today it has entered into a binding letter of intent with Viratech, Inc., a company which holds the exclusive license to market proprietary and patented cancer diagnostic and treatment protocols, including the unified cancer theory, which is a multi-disciplinary oncological approach to identify the physiological mechanism of action for all cancers, the stage zero cancer protocol, an intellectual property pool consisting of best method practices of dealing with and managing individual cancer patients, and an early detection diagnostic system. The letter of intent calls for a 1-100 reverse restructuring of the company’s common share capital, an increase in authorized common share capital to 2 billion shares, and 20 million shares of Series B Preferred Stock. A Notice of Special Shareholder’s Meeting set for July 16, 2011 to effectuate the measures can be found on the Company’s website.
About Imperia Entertainment, Inc.
Imperia Entertainment, Inc. is a diversified entertainment company, engaged in film development and production. The acquisition of Viratech marks the Company’s expansion into the biotech industry. Imperia will continue to own its interest in the Company’s award winning feature film, “Say it in Russian,” (http://sayitinrussianmovie.com), winner of seven major film awards in 2009, and the television series, “Autograph.”
This press release contains statements, which may constitute “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Imperia Entertainment, Inc. and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions.
Imperia Entertainment, Inc.
Jeff Ritchie: 818-554-1911 or
info@imperiaentertainment.com
SOURCE Imperia Entertainment, Inc.
?